Development and evaluation of floating microspheres of curcumin

Tropical Journal of Pharmaceutical Research

Volumn 11, Issue 5, 2012, Pages 713-719

  Kumar, Kapil ^a,b   Rai, A K ^c  

^a NIMS UNIVERSITY   (India)

^b Affiliated to Uttarakhand Technical University   (India)

^c PRANVEER SINGH INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Curcumin; Ethyl cellulose; Eudragit; Floating microspheres; Gastro retentive; Hydroxylpropyl methylcellulose; Sustained release

Indexed keywords

ALCOHOL; CURCUMIN; DICHLOROMETHANE; ETHYL CELLULOSE; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; MICROSPHERE;

ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; FLOW RATE; IN VITRO STUDY; MEAN RESIDENCE TIME; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROCESS DEVELOPMENT; SCANNING ELECTRON MICROSCOPY; STOMACH PH; SURFACE PROPERTY;

EID: 84868022402     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Norman GB. Herbal drugs and phytopharmaceuticals. A Handbook for Practice on a Scientific Basis. New York: Medpharm Scientific Publishers, Stuttgart and CRC Press, 2001; 2: 230-48.
2. Chien YW. Novel drug delivery system, Marcel Dekker Inc Publications: New York, 1992; 2(50): 16172.
3. Khar RK, Vyas SP. Targeted and controlled drug delivery novel carrier system, CBS Publishers and Distributors: New Delhi, 2002; 1: 417-54.
4. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floatng drug delivery systems: A review, AAPS Pharm Sci Tech 2005; 6(3): 372-390.
5. Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat, Acta Pharmacol Toxicol, 1978; 43: 86-92.
6. Anand P, Kunnumakkara AB, Newman RA. Bioavailability of Curcumin: Problems and Promises, Mol Pharmaceutics, 2007; 4 (6): 807-818.
7. Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach, Pharm Sci, 1992; 81: 135-140.
8. Parasuram RR, Moidutty L, Chetan H. Preparation and evaluation of delayed release aceclofenac microspheres, Asian J Pharm, 2008; 2(4): 52-54.
9. Aulton ME, Pharmaceutics: The Science of Dosage Form Design, Churchill Livingstone, Elsevier Science Ltd, 2002; 2:315-2320.
10. Trivedi P, Verma ML, Garud N. Preparation and characterization of aceclofenac microspheres, Asian J Pharm, 2008; 2: 110-115
11. Patel AR, Mahajan AN, Shah DA. Preparation and in vitro characterization of porous carrierbased floating microspheres of model drug for gastric delivery, Der Pharmacia Lettre, 2011; 3(3):432-42.
12. Pusp RN, Myung K C, Hoo K C. Preparation of floating microspheres for fish farming, Int J Pharm, 2007; 341: 85-90.
13. Srivastava A, Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation, Acta Pharm, 2005; 55: 277-285.
14. Maheswari U, Jain S, Bhadra D, Jain NK. Floating microspheres bearing acetohydroxamic acid for the treatment of H. pylori, J Pharm Pharmacol, 2003; 55: 1607-1613.
15. Higuchi WI. Analysis of data on the medicament release from ointments, J Pharm Sci, 1962; 51:802-804
16. Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm, 1983; 15: 25-35.
17. Rahman MH, Telny T, Kumaraswamy K. Comparative evaluation of HPMC K100 and poloxamer 188-influence on release kinetics of Curcumin in floating microspheres, R J Pharm Chem Biol Sci, 2010;1(2): 28-34.